Ramesh Shankar Wednesday, December 25, 2024, 08:00 Hrs [IST] The Karnataka State Registered Pharmacists Organization has recently brought to the notice of ...

Karnataka is probably the 14th state to have a Food and Drugs Administration (FDA) in the country. The FDA’s efficiency directly contributes to effective service delivery in healthcare, food and drug ...

Neurocrine Biosciences’ US FDA approved crinecerfont is available for children and adults to treat classic congenital adrenal hyperplasia: San Diego Tuesday, December 24, 2024, ...

Aethlon Medical updates ability of its medical device ‘Hemopurifier’ to capture H5N1 Bird Flu: San Diego Tuesday, December 24, 2024, 18:00 Hrs [IST] Aethlon Medical, Inc, a me ...

European Wellness Biomedical Group launches new initiative to investigate Klotho’s role in combating age-related diseases: Heidelberg, Germany Tuesday, December 24, 2024, 10:00 ...

Chola Mahendran elected president of TN PTA, MS Saravanan general secretary: Our Bureau, Chennai Tuesday, December 24, 2024, 16:15 Hrs [IST] The annual general body meeting of the ...

Venus Remedies partners with NSDC to pioneer workforce development through skill certification: Our Bureau, Mumbai Tuesday, December 24, 2024, 15:45 Hrs [IST] Venus Remedies Limit ...

LEIBINGER significantly expands presence in Brazil to meet demands of local industries: Tuttlingen, Germany Tuesday, December 24, 2024, 17:00 Hrs [IST] LEIBINGER, a global leader ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation for the medicine givinostat (Duvyzat) of Italfarmaco to treat Duchenne muscular ...

GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae: Our Bureau, Bengaluru Monday, December 23, 2024, 14 ...

US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...

Idorsia Ltd has provided an update on the ongoing exclusive negotiations for the global rights to aprocitentan. On November 27, 2024, the company announced that it had entered exclusive negotiations ...